Drug Pricing and Value in Oncology

Oncologist - United States
doi 10.1634/theoncologist.2010-s1-24
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Pcn256 - Indication-Specific Pricing in Oncology: How Will U.S. Payers Determine Value Amid This Growing Trend?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Rarefied Drug Pricing

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2014English

Prm7 Drug Development and Pharmaceutical Pricing in the United States: The Influence of Drug Intended Outcomes of Drug Pricing

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Clinically Relevant Drug-Drug Interactions in Oncology

British Journal of Clinical Pharmacology
Pharmacology
1998English

PHP9 Drug Pricing in Bosnia and Herzegovina

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Biomarkers in Oncology Drug Development

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2008English

Drug Interaction in Psycho-Oncology: Antidepressants and Antineoplastics

Pharmacology
MedicinePharmacology
2011English

Value-Based Pricing: L’Enfant Terrible?

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2017English

The “Value” of Value in Gynecologic Oncology Practice in the United States: Society of Gynecologic Oncology Evidence-Based Review and Recommendations

Gynecologic Oncology
GynecologyOncologyObstetrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy